Hamburg, 14 January 2021 Toadlet peptide transforms into a deadly weapon against bacteria Researchers at the Technion – Israel Institute of Technology and EMBL Hamburg have discovered remarkable molecular properties of an antimicrobial peptide from the skin of the Australian toadlet. The discovery could inspire the development of novel synthetic drugs to combat bacterial infections
Hamburg, 16 October 2020 Welcome: Meytal Landau Amyloids are protein aggregates known for their role in neurodegenerative diseases like Alzheimer’s or Parkinson’s. They’re also secreted by some bacteria. During a one-year sabbatical at EMBL Hamburg, Israeli structural biologist Meytal Landau made use of the site's infrastructure to deepen her study of amyloids in bacteria and in human diseases. She has now joined EMBL as an associate group leader.
Hamburg, 13 October 2020 How deadly parasites ‘glide’ into human cells A group of scientists led by EMBL Hamburg’s Christian Löw provide insights into the molecular structure of proteins involved in the gliding movements through which the parasites causing malaria and toxoplasmosis invade human cells.
Hamburg, 29 July 2020 EMBL releases online course on solution scattering from biological macromolecules The Svergun group at EMBL Hamburg has released the course ‘Solution Scattering from Biological Macromolecules’ in an online format for the first time. The course explores different aspects of small-angle X-ray scattering (SAXS) for studying the structure of macromolecules.
Hamburg, 28 January 2020 Meytal Landau: a visiting researcher in Hamburg When structural biologist Meytal Landau was considering her options for a one-year sabbatical from her lab at Technion – a scientific research institute in Haifa, Israel – one of her main criteria was to find an institute where she could broaden her knowledge and experience of cryo-electron microscopy. EMBL Hamburg was an obvious contender: Landau would have access to the cutting-edge infrastructure at the Centre for Structural Systems Biology (CSSB), and she already had links with Matthias Wilmanns, Head of EMBL Hamburg, as well as the scientists in charge of the EMBL synchrotron beamlines in Hamburg.
Hamburg, 6 December 2019 Understanding a key player in melanoma A new paper describes the mechanism that the transcription factor MITF, a key member of the MIT/TFE family, uses for selecting its partners. It is the result of a collaboration between the groups of Matthias Wilmanns, Head of EMBL Hamburg, and Eiríkur Steingrímsson from the University of Iceland, Reykjavík, and new chair of the EMBL Council. MITF plays a key role in the development of Melanoma. Understanding its function could be key for treating this disease.